Lonnie's career in cancer therapy/diagnosis is > 40 yrs; he developed & sold products to pharma, raised $$, managed & sold businesses, works w/ leading experts in the cancer field. He did lab & clinical research, won awards at Lederle (Pfizer), sold MAbs to Adria/BI, helped get a CA vaccine approved, served as VP, COO & CEO. He licensed issued patents to start-up ARIZ, has new IP for devices & drugs that kill cancer in safe & effective ways.

Dr. Kester earned his BS in biology & received a biochemistry PhD from SUNY. He joined Penn State in 1998, he served as interim chair of the Department of Pharmacology & currently is a Professor of Pharmacology at the U.VA. Dr. Kester is a founder & CMO of Keystone Nano. ARIZ and KN have a strategic partnership. His expertise in drug delivery devices is well known, as is his ability to publish significant scientific research & obtain patents.

Glenn has >25 years of experience in the medical industry as a leader, senior executive, corporate officer & scientist with extensive business development, strategic planning, marketing and financing experience. Glenn has raisied over $300M, had a leading role in 3 IPOs. He has expertise in RNAi drug delivery devices, was a founder of Enzon, a pioneer of Peg technology, a key component of ARIZ’s technology. Kazo is President of Prolong Pharma.

Effie has provided consulting services to major biopharma companies on device & drug development as well as worked on preclinical and clinical studies. She is an expert in stem cell therapy in myeloma patients. She was a Senior Fellow, Hematology & Medical Genetics & has a Certificate in Medical Management from U.WA, is a reviewer for LSDF & Keiretsu. She was Executive Director of Partners in Personal Oncology Institute Seattle w/ Tony Blau.